Anti-Heparanase Aptamers as Potential Diagnostic and Therapeutic Agents for Oral Cancer

Autor: Juha Risteli, Célia Martins Cortez, Suzanne Simmons, Paul Brenchley, Sotiris Missailidis, Hannaleena Jämsä, Tuula Salo, Carolina Cavalcante Bitu, Sirpa Salo, Sini Nurmenniemi, Edward A. McKenzie, Dilson Silva, Pia Nyberg, Carlos E. B. deAlmeida
Přispěvatelé: Department of Oral and Maxillofacial Diseases
Jazyk: angličtina
Rok vydání: 2014
Předmět:
lcsh:Medicine
MAMMALIAN HEPARANASE
Biochemistry
Synthetic Nucleic Acids
Extracellular matrix
0302 clinical medicine
Drug Stability
DNA APTAMERS
Nucleic Acids
Molecular Cell Biology
Drug Discovery
Medicine and Health Sciences
Cytotoxic T cell
Biomacromolecule-Ligand Interactions
Cytotoxicity
lcsh:Science
IN-VIVO
FIBROBLAST-GROWTH-FACTOR
Glucuronidase
Mouth neoplasm
0303 health sciences
Multidisciplinary
Chemistry
Aptamers
Nucleotide

Head and Neck Tumors
3. Good health
Gene Expression Regulation
Neoplastic

Oncology
LASER-DESORPTION/IONIZATION
030220 oncology & carcinogenesis
Mouth Neoplasms
Research Article
Biotechnology
EXPRESSION
Drug Research and Development
Aptamer
education
Biophysics
03 medical and health sciences
In vivo
Cell Line
Tumor

EXTRACELLULAR-MATRIX
Humans
Heparanase
Neoplasm Invasiveness
030304 developmental biology
Pharmacology
lcsh:R
Biology and Life Sciences
Cancers and Neoplasms
MASS-SPECTROMETRY
Cell Biology
CELL CARCINOMA
Molecular biology
313 Dentistry
PROTEIN INTERACTIONS
Cell culture
Cancer research
lcsh:Q
3111 Biomedicine
Clinical Medicine
Zdroj: PLoS ONE
PLoS ONE, Vol 9, Iss 10, p e96846 (2014)
ISSN: 1932-6203
Popis: Heparanase is an endoglycosidase enzyme present in activated leucocytes, mast cells, placental tissue, neutrophils and macrophages, and is involved in tumour metastasis and tissue invasion. It presents a potential target for cancer therapies and various molecules have been developed in an attempt to inhibit the enzymatic action of heparanase. In an attempt to develop a novel therapeutic with an associated diagnostic assay, we have previously described high affinity aptamers selected against heparanase. In this work, we demonstrated that these anti-heparanase aptamers are capable of inhibiting tissue invasion of tumour cells associated with oral cancer and verified that such inhibition is due to inhibition of the enzyme and not due to other potentially cytotoxic effects of the aptamers. Furthermore, we have identified a short 30 bases aptamer as a potential candidate for further studies, as this showed a higher ability to inhibit tissue invasion than its longer counterpart, as well as a reduced potential for complex formation with other non-specific serum proteins. Finally, the aptamer was found to be stable and therefore suitable for use in human models, as it showed no degradation in the presence of human serum, making it a potential candidate for both diagnostic and therapeutic use.
Databáze: OpenAIRE